SELECTION OF ANTIBACTERIAL THERAPY IN VARIOUS INFLAMMATORY DISEASES OF BRONCHES


DOI: https://dx.doi.org/10.18565/pharmateca.2018.3.34-39

G.L. Ignatova, V.N. Antonov

Department of Therapy of the ICPE FSBEI HE “South Ural State Medical University” of RMH, Chelyabinsk, Russia
The article provides data on rational selection of antibacterial therapy depending on nosology. Acute and chronic bronchitis, chronic obstructive pulmonary disease, despite the common etiology and pathogenetic mechanisms, have fundamental differences in the management of patients and the main approaches to the administration of background or etiotropic therapy. In addition, the clinical manifestations of these diseases depend on the degree of manifestation of bronchial or systemic inflammation in the tracheobronchial tree. Particular attention is paid to the use of cefditoren, III generation cephalosporin, in the practice. Clinical cases of real patients are discussed.
Keywords: acute bronchitis, chronic bronchitis, chronic obstructive pulmonary disease, rational antibacterial therapy, cefditoren

About the Autors


Corresponding author: G.L. Ignatova – MD, Professor, Head the Department of Therapy of the ICPE FSBEI HE “South Ural State Medical University” of RMH, Chelyabinsk, Russia; e-mail: iglign@mail.ru


Бионика Медиа